Glp-1 Receptor Agonist Side Effect Profile

Overview of Glp-1 Receptor Agonist Side Effect Profile

Abstract Background Glucagon-like peptide-1 receptor agonists ( GLP -1RAs) have transformed the management of type 2 diabetes and obesity by enhancing glycemic control, facilitating weight reduction, and diminishing cardiovascular risk. But as more people use them, there is increased interest in understanding the side effects and ...

Such details provide a deeper understanding and appreciation for Glp-1 Receptor Agonist Side Effect Profile.

Caution is needed until the harms are better understood Glucagon-like peptide-1 ( GLP-1 ) receptor agonists have emerged as a promising treatment for obesity and diabetes. Over the past few years, recognition has grown of their transformational potential for the more than one billion people living with obesity and over 800 million with diabetes globally.12 However, appreciation of the risks is ...

Managing Common GLP 1-Receptor Agonist Side Effects Glucagon-like peptide-1 receptor agonists ( GLP-1 RAs) have become an essential part of the obesity management medication tool kit. Side effects are, however, common and are more likely to occur in the first few weeks after initiation of therapy and with dose escalations. The most common side effects are gastrointestinal (GI) and include ...